Advanced Proteome Therapeutics Announces Warrant Extension
Krantz Ben2024-07-19T22:18:14-04:00Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), is dedicating additional resources to its SARS-CoV-2 protease inhibitor program.